1. Targeted inhibition of HER-2 positive breast cancer cells by trastuzumab functionalized pullulan-doxorubicin nanoparticles. (September 2022) Authors: Xu, Ruiling; Sui, Junhui; Zhao, Mingda; Yang, Yuedi; Tong, Lei; Liu, Yongmei; Sun, Yong; Fan, Yujiang; Liang, Jie; Zhang, Xingdong Journal: Polymer testing Issue: Volume 113(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗